Association of a G994 → T (Val279 → phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in japanese patients with nonfamilial hypertrophic cardiomyopathy

Y. Yamada, S. Ichihara, Hideo Izawa, M. Tanaka, M. Yokota

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Plasma platelet-activating factor acetylhydrolase(PAF-AH) acts as a key defense against oxidative stress by hydrolyzing PAF and oxidized phospholipids. Deficiency of the activity of this enzyme may thus potentially result in predisposition to myocardial damage. The possible role of the G994 (V allele) → T (F allele) polymorphism of the PAF-AH gene in modulating cardiac function was investigated in 142 Japanese subjects with nonfamilial hypertrophic cardiomyopathy (HCM). Logistic regression analysis adjusted for age, sex, height, and body weight revealed that the frequency of the F allele was significantly higher in HCM patients than in 284 healthy controls. Echocardiographic examination revealed that left ventricular (LV) end-diastolic and end-systolic dimensions were significantly greater in HCM patients with the FF genotype than in those with the VV genotype. Cardiac catheterization revealed that LV end-diastolic pressure was significantly higher, whereas the LV ejection fraction was significantly smaller, for HCM patients with the F allele than for those with the VV genotype. Interstitial fibrosis was significantly more severe in HCM subjects with the FF genotype than in those with the VV genotype. These results suggest that the G994 → T (Val279 → Phe) polymorphism in the plasma PAF-AH gene may exacerbate cardiac damage in Japanese individuals with nonfamilial HCM, although this polymorphism is unlikely to be a causative factor for this condition.

Original languageEnglish
Pages (from-to)436-441
Number of pages6
JournalJournal of Human Genetics
Volume46
Issue number8
DOIs
Publication statusPublished - 23-08-2001
Externally publishedYes

Fingerprint

Platelet Activating Factor
Hypertrophic Cardiomyopathy
Genotype
Genes
Alleles
Cardiac Catheterization
Gene Frequency
Stroke Volume
Phospholipids
Oxidative Stress
Fibrosis
Logistic Models
Body Weight
Regression Analysis
Blood Pressure
Enzymes

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)
  • Genetics

Cite this

@article{b09f01120f4b41629b32f052ec256916,
title = "Association of a G994 → T (Val279 → phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in japanese patients with nonfamilial hypertrophic cardiomyopathy",
abstract = "Plasma platelet-activating factor acetylhydrolase(PAF-AH) acts as a key defense against oxidative stress by hydrolyzing PAF and oxidized phospholipids. Deficiency of the activity of this enzyme may thus potentially result in predisposition to myocardial damage. The possible role of the G994 (V allele) → T (F allele) polymorphism of the PAF-AH gene in modulating cardiac function was investigated in 142 Japanese subjects with nonfamilial hypertrophic cardiomyopathy (HCM). Logistic regression analysis adjusted for age, sex, height, and body weight revealed that the frequency of the F allele was significantly higher in HCM patients than in 284 healthy controls. Echocardiographic examination revealed that left ventricular (LV) end-diastolic and end-systolic dimensions were significantly greater in HCM patients with the FF genotype than in those with the VV genotype. Cardiac catheterization revealed that LV end-diastolic pressure was significantly higher, whereas the LV ejection fraction was significantly smaller, for HCM patients with the F allele than for those with the VV genotype. Interstitial fibrosis was significantly more severe in HCM subjects with the FF genotype than in those with the VV genotype. These results suggest that the G994 → T (Val279 → Phe) polymorphism in the plasma PAF-AH gene may exacerbate cardiac damage in Japanese individuals with nonfamilial HCM, although this polymorphism is unlikely to be a causative factor for this condition.",
author = "Y. Yamada and S. Ichihara and Hideo Izawa and M. Tanaka and M. Yokota",
year = "2001",
month = "8",
day = "23",
doi = "10.1007/s100380170042",
language = "English",
volume = "46",
pages = "436--441",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Association of a G994 → T (Val279 → phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in japanese patients with nonfamilial hypertrophic cardiomyopathy

AU - Yamada, Y.

AU - Ichihara, S.

AU - Izawa, Hideo

AU - Tanaka, M.

AU - Yokota, M.

PY - 2001/8/23

Y1 - 2001/8/23

N2 - Plasma platelet-activating factor acetylhydrolase(PAF-AH) acts as a key defense against oxidative stress by hydrolyzing PAF and oxidized phospholipids. Deficiency of the activity of this enzyme may thus potentially result in predisposition to myocardial damage. The possible role of the G994 (V allele) → T (F allele) polymorphism of the PAF-AH gene in modulating cardiac function was investigated in 142 Japanese subjects with nonfamilial hypertrophic cardiomyopathy (HCM). Logistic regression analysis adjusted for age, sex, height, and body weight revealed that the frequency of the F allele was significantly higher in HCM patients than in 284 healthy controls. Echocardiographic examination revealed that left ventricular (LV) end-diastolic and end-systolic dimensions were significantly greater in HCM patients with the FF genotype than in those with the VV genotype. Cardiac catheterization revealed that LV end-diastolic pressure was significantly higher, whereas the LV ejection fraction was significantly smaller, for HCM patients with the F allele than for those with the VV genotype. Interstitial fibrosis was significantly more severe in HCM subjects with the FF genotype than in those with the VV genotype. These results suggest that the G994 → T (Val279 → Phe) polymorphism in the plasma PAF-AH gene may exacerbate cardiac damage in Japanese individuals with nonfamilial HCM, although this polymorphism is unlikely to be a causative factor for this condition.

AB - Plasma platelet-activating factor acetylhydrolase(PAF-AH) acts as a key defense against oxidative stress by hydrolyzing PAF and oxidized phospholipids. Deficiency of the activity of this enzyme may thus potentially result in predisposition to myocardial damage. The possible role of the G994 (V allele) → T (F allele) polymorphism of the PAF-AH gene in modulating cardiac function was investigated in 142 Japanese subjects with nonfamilial hypertrophic cardiomyopathy (HCM). Logistic regression analysis adjusted for age, sex, height, and body weight revealed that the frequency of the F allele was significantly higher in HCM patients than in 284 healthy controls. Echocardiographic examination revealed that left ventricular (LV) end-diastolic and end-systolic dimensions were significantly greater in HCM patients with the FF genotype than in those with the VV genotype. Cardiac catheterization revealed that LV end-diastolic pressure was significantly higher, whereas the LV ejection fraction was significantly smaller, for HCM patients with the F allele than for those with the VV genotype. Interstitial fibrosis was significantly more severe in HCM subjects with the FF genotype than in those with the VV genotype. These results suggest that the G994 → T (Val279 → Phe) polymorphism in the plasma PAF-AH gene may exacerbate cardiac damage in Japanese individuals with nonfamilial HCM, although this polymorphism is unlikely to be a causative factor for this condition.

UR - http://www.scopus.com/inward/record.url?scp=0034742040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034742040&partnerID=8YFLogxK

U2 - 10.1007/s100380170042

DO - 10.1007/s100380170042

M3 - Article

C2 - 11501940

AN - SCOPUS:0034742040

VL - 46

SP - 436

EP - 441

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 8

ER -